MeSH tree: C06.405.205.265.231
There is a strong connection between inflammatory bowel disease (IBD) and spondyloarthritis—a condition that causes pain and stiffness in the joints. The risk is particularly high among patients with Crohn's disease and those ...
Oct 28, 2024
0
23
Researchers in the lab of Michael Sigal at the Max Delbrück Center and Charité—Universitätsmedizin Berlin have elucidated the role of the p53 gene in ulcerative colitis. The study, published in Science Advances, suggests ...
Oct 25, 2024
0
56
Abdominal pain, diarrhea, and debilitating fatigue define the daily lives of millions of people worldwide who suffer from chronic bowel disease. Most of these individuals are diagnosed in their youth, and the disease's progression ...
Oct 17, 2024
0
29
Across the Western world, the prevalence of inflammatory bowel diseases, which have no cure, is rising. In Denmark alone, 50,000 people suffer from either Crohn's disease or ulcerative colitis, which represents a doubling ...
Oct 11, 2024
0
50
The Crohn's & Colitis Foundation released findings from its latest health care access survey, revealing that more than 40% of inflammatory bowel disease (IBD) patients have made significant financial trade-offs to afford ...
Oct 8, 2024
0
22
Colorectal cancer cases are rising among younger people, striking even folks without obvious risk factors.
Oct 1, 2024
0
27
A research team led by Junior Associate Professor Kazuo Takayama, from the Department of Cell Growth and Differentiation, recently constructed a new model of inflammatory bowel disease using iPS cells that enables more accurate ...
Sep 30, 2024
0
56
Cleveland Clinic researchers have discovered a new bacterium that weakens the immune system in the gut, potentially contributing to certain inflammatory and infectious gut diseases.
Sep 26, 2024
0
98
An international placebo-controlled study led by Cedars-Sinai suggests that a targeted drug therapy that was developed by researchers at Cedars-Sinai is safe and effective at helping people with moderate to severe ulcerative ...
Sep 26, 2024
0
43
The U.S. Food and Drug Administration has approved Johnson & Johnson's Tremfya (guselkumab) for the treatment of adults with moderately to severely active ulcerative colitis.
Sep 17, 2024
0
40
